drugset

drugset / Trial / NCT04041219

Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

NCT04041219 ↗

Phase 4 Completed 10 enrolled Mayo Clinic

NaSingle-groupOpen-labelTreatment

Summary

Researchers are trying to learn more about using sublingual (absorption under the tongue) tacrolimus in blood and marrow transplant patients.

Timeline

Start: 2019-06-17
Primary completion: 2019-10-08
Completion: 2019-10-08

Publications

May HP, Bartoo GT, Wolf RC, Shah MV, Litzow MR, Hogan WJ, Alkhateeb H. Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot study. J Oncol Pharm Pract. 2022 Mar;28(2):387-394. doi: 10.1177/1078155221995230. Epub 2021 Feb 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	0.04 mg/kg	Other

Indications